InsiderTrades

Form 4 for AMPH Amphastar Pharmaceuticals, Inc.

Accepted 2025-12-18 00:00:00 ET · period of report 2025-12-17 · accession 0001645326-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-12-18 2025-12-17 AMPH Zhou Rong SENIOR EVP, PRODUCTION CENTER M - OptEx $11.33 +9,787 147.8K +7% +$110.9K
D 2025-12-18 2025-12-17 AMPH Zhou Rong SENIOR EVP, PRODUCTION CENTER S - Sale+OE $26.20 -9,787 138.0K -7% -$256.4K
D 2025-12-18 2025-12-17 AMPH Zhou Rong SENIOR EVP, PRODUCTION CENTER M - OptEx $0.00 -9,787 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2025-12-17 M A 9,787 $11.33 147,830 D — — (F1) Includes 545 shares acquired on May 31, 2025 and one share acquired on November 30, 2025 under the Issuer's 2014 Employee Stock Purchase Plan.
2 Common Common Stock 2025-12-17 S D 9,787 $26.20 138,043 D — — (F2) The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.97 to $26.50, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.
3 Derivative Employee Stock Option (right to buy) 2025-12-17 M D 9,787 $0.00 0 D $11.33 · — to 2026-03-17 9,787 Common Stock (F5) Shares subject to the option are fully vested and immediately exercisable.